Morpho (MORPHO) is 7.7× the size of Compound (COMP) by market capitalisation. Over the past 1 year, MORPHO is ahead by 72.3 percentage points (MORPHO +38.2% against COMP -34.1%). Their daily returns move loosely together (correlation 0.49 across 398 shared trading days). MORPHO has been the more volatile of the two, at 94% annualised against COMP's 80%.
MORPHOCOMP
0.49over 398 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | MORPHO | COMP |
|---|---|---|
| Max drawdown (400d) | -51.0% | -65.4% |
| Risk-adjusted return (90d) | 0.18 | 0.33 |
| Best 30 days (past year) | +77.8% | +41.3% |
| Worst 30 days (past year) | -44.8% | -40.7% |
Relative strength over 90 days: COMP outperformed MORPHO by 7.0% — measured on the MORPHO/COMP ratio, so it holds regardless of market direction.